{
    "2021-11-04": [
        [
            {
                "time": "2021-11",
                "original_text": "【兴证医药】医药持仓比例历史低位，自下而上布局2022年-2021年11月投资月报",
                "features": {
                    "keywords": [
                        "医药",
                        "持仓比例",
                        "历史低位",
                        "自下而上",
                        "布局"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "高瓴，正在抛弃医药股？",
                "features": {
                    "keywords": [
                        "高瓴",
                        "医药股",
                        "抛弃"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "如果现在就是医药极度悲观的底部，未来该如何布局？",
                "features": {
                    "keywords": [
                        "医药",
                        "悲观",
                        "底部",
                        "布局"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "凯莱英：公司正按照发行H股的时间表推行该项工作",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "H股",
                        "发行",
                        "时间表"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "北向资金稳步加仓连续6日净买入，新能源、大消费集体获抢筹",
                "features": {
                    "keywords": [
                        "北向资金",
                        "加仓",
                        "新能源",
                        "大消费",
                        "净买入"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "新能源",
                        "大消费"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "Q3",
                "original_text": "高瓴资本3季度只减仓不加仓：安全边际、成长性重定位",
                "features": {
                    "keywords": [
                        "高瓴资本",
                        "减仓",
                        "安全边际",
                        "成长性",
                        "重定位"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "Q3",
                "original_text": "高瓴资本三季度只减仓不加仓，安全边际与成长性需重新定位",
                "features": {
                    "keywords": [
                        "高瓴资本",
                        "三季度",
                        "减仓",
                        "安全边际",
                        "成长性",
                        "重新定位"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}